Agreement signedPublished 16 Mar 2023

Laboratory Corporation of America Holdings /
Enzo Biochem, Inc.

Laboratory Corporation of America Holdings to buy Enzo Biochem clinical labs business

Terms
Not stated
Stage
Agreement signed
Buy side: Laboratory Corporation of America Holdings
Buy sideLaboratory Corporation of America Holdings
Target: Enzo Biochem, Inc.
TargetEnzo Biochem, Inc.
Source · 16 Mar 2023
Buy side: Laboratory Corporation of America Holdings
Buy sideLaboratory Corporation of America Holdings
Target: Enzo Biochem, Inc.
TargetEnzo Biochem, Inc.
01 / BuyerLaboratory Corporation of America Holdings
02 / TargetEnzo Biochem, Inc.
01

What happened

Laboratory Corporation of America Holdings agreed to purchase assets and assume certain liabilities of Enzo Biochem, Inc.’s clinical labs business. The transaction is subject to shareholder approval and other closing conditions.

The purchase price is approximately $146,000,000 in cash, subject to adjustments.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Laboratory Corporation of America Holdings to buy Enzo Biochem clinical labs business

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.